The Valley Desk

NCT00091598 · Interventional trial

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Overall registry status Completed

Phase 3

Conditions Pulmonary Hypertension

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov